We're bringing an extra episode from our show What's New. The FDA has yet to approve any drugs for life extension. But biotech company Loyal is now a step closer to bringing one to market—for dogs. 

Learn about your ad choices: <a href="https://dovetail.prx.org/ad-choices">dovetail.prx.org/ad-choices</a>

We're bringing an extra episode from our show What's New. The FDA has yet to approve any drugs for life extension. But biotech company Loyal is now a step closer to bringing one to market—for dogs. Learn about your ad choices: dovetail.prx.org/ad-choices

We're bringing an extra episode from our show What's New. The FDA has yet to approve any drugs for life extension. But biotech company Loyal is now a step closer to bringing one to market—for dogs. 

Learn about your ad choices: <a href="https://dovetail.prx.org/ad-choices" rel="noopener noreferrer">dovetail.prx.org/ad-choices</a>

From What's New: A Life-Extension Drug for Big Dogs Is Getting Closer to Reality

Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.

Business

Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.

Share From What's New: A Life-Extension Drug for Big Dogs Is Getting Closer to Reality

Sign up to save your podcasts

From What's New: A Life-Extension Drug for Big Dogs Is Getting Closer to Reality

From What's New: A Life-Extension Drug for Big Dogs Is Getting Closer to Reality

More shows like Business, Spoken

Uncanny Valley | WIRED

Science, Spoken

What's New

The Daily

Security, Spoken

Citadel Dropouts: a Game of Thrones Podcast